Soluble levels of sCD40L and s4-1BB are associated with a poor prognosis in elderly patients with colorectal cancer.
Petrus M A LimaLeuridan C TorresMário Rino MartinsMarina C da MattaJurema T O LimaMaria J G de MelloLeuridan Cavalcante TorresEvandro B CintraClara C R LiraEduardo J A da FonteNora M ForonesPublished in: Journal of surgical oncology (2019)
We concluded that sCD40L and s4-1BB molecules may be prognostic biomarkers, since the reduction in plasma levels of these molecules was associated with disease progression.